Verano Holdings just printed Q2 2026 numbers that quietly tightened the screws on its loss profile while the stock came into the release under pressure, down roughly 9% over the past month and about 9% over three months to close at CA$6.93 on October 30. The headline is a cannabis operator still in the red, with a Q2 loss of US$13.4 million, yet posting revenue of US$217.9 million and a smaller loss per share than in Q1. Market emotion is still grading Verano as a struggler, while the actual earnings tell a slower, more nuanced repair story.
Love Verano Holdings' revenue base but concerned about ongoing losses and pressure on the share price? Check out the list of solid balance sheet and fundamentals stocks (6 results) .
Q2 2026 Earnings Summary
-
Revenue (Q2 2026 vs. Q2 2025):US$217.9 million vs. US$202.3 million (single digit percentage increase in quarterly sales)
-
Net Loss (Q2 2026 vs. Q2 2025):US$13.4 million loss vs. US$19.2 million loss (loss narrowed quarter on quarter year over year)
-
Basic EPS (Q2 2026 vs. Q2 2025):US$0.18 loss per share vs. US$0.26 loss per share (per share loss reduced compared with the prior comparable quarter)
-
Trailing 12-Month Net Loss (Q2 2026 TTM vs. Q2 2025 TTM):US$258.5 million loss vs. US$345.9 million loss (full year loss over the trailing period reduced)
Verano's cash flow and buybacks are both moving again. Ask Charlie what Verano plans to do with its cash .
Verano's Bull Case Hinges On Cash, Not Hype
Optimistic views on Verano Holdings hinge on turning footprint, brands and cost work into real, recurring cash.
"The main thing that has to go right is that Verano converts its strong medical footprint, product rollouts and cost efficiency program into sustained cash generation, while managing price pressure and higher planned 2026 CapEx."
The latest quarter points to some of that playing out. Retail transactions grew, adjusted EBITDA margin held at 24% and operating cash flow reached US$49 million, the highest since early 2023. At the same time, the raised 2026 CapEx guide to US$54 to US$60 million confirms the cash generation goal is working against a heavier investment load.
Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there .
Verano Bear Case: Margin Strain Still Unresolved
The harshest critics argue that Verano Holdings is stuck in a discount spiral that taxes and cost cuts will struggle to fix.
"While management points to operational efficiency efforts and prior SG&A reductions as a way to counter discounting, the Q2 2026 gross profit of $100 million at a 46% margin and adjusted EBITDA of $51 million at a 24% margin both declined versus the prior year. This indicates that promotional activity and price compression may continue to offset future cost programs and weigh on margin resilience."
Q3 results give that view partial backing. Adjusted EBITDA margin stayed at 24% and wholesale revenue fell on lighter campaigns, so margin repair looks stalled. Retail strength and a US$4 million net loss point to better earnings quality and stronger operating cash flow; however, the specific milestone bearish investors watch, clear margin expansion without heavy discounting, has not arrived.
Hunt Quiet Disconnects In Plain Sight
Verano Holdings just reported earnings that showed its share price and fundamentals reacting on separate paths. The real opportunity is finding stocks that could be undervalued before the market corrects them.
-
Company 1 - 35% below our estimate - uses acquisitions and digital delivery centers to turn a growing project backlog into higher margin consulting work.
-
Company 2 - 46% below our estimate - targets higher income shoppers as new flagship sites and faster e commerce support full price sell through and curb markdown dependence.
-
Company 3 - 21% below our estimate - converts a growing aerospace backlog and an aftermarket-focused acquisition into recurring work on long lived aircraft platforms.
Those are three of them. See the full list of 3 companies trading below our fair value estimates →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include VRNO .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
